KLERTUGO Trademark

Trademark Overview

On Monday, June 21, 2021, a trademark application was filed for KLERTUGO with the United States Patent and Trademark Office. The USPTO has given the KLERTUGO trademark a serial number of 90786045. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Principia Biopharma Inc.. The KLERTUGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
klertugo

General Information

Serial Number90786045
Word MarkKLERTUGO
Filing DateMonday, June 21, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrincipia Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NamePrincipia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, June 24, 2021NEW APPLICATION ENTERED
Wednesday, July 28, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, September 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 9, 2021ASSIGNED TO LIE
Thursday, September 9, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 21, 2022SOU EXTENSION 1 FILED
Friday, October 21, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023SOU EXTENSION 2 FILED
Monday, April 24, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 3 FILED
Thursday, November 9, 2023SOU EXTENSION 3 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2024SOU EXTENSION 4 FILED
Thursday, April 25, 2024SOU EXTENSION 4 GRANTED
Friday, April 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 5 GRANTED
Friday, October 25, 2024SOU EXTENSION 5 FILED

Related Keywords

klertugo pharmaceutical preparations diseases preventing disorders treating blood tumors lesions skin